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Thymoma is an epithelial neoplasm of the thymus, which commonly lies in the anterior mediastinum and,
therefore, an intrathoracic origin is considered to be rare. This report presents a case of giant thymoma arising in
the thoracic cavity. A 61-year-old male presented with a chronic cough and breathlessness. Chest CT revealed a
well enhanced giant mass approximately 18 cm in diameter in the right thoracic cavity. FDG-PET showed that the
SUVmax of the tumor was 5.0 in the center and almost 2.5 in the surrounding area. A trans- bronchial needle
biopsy was performed to find atypical cells. Surgery was scheduled based on the radiological and histological
findings. A well-defined giant mass in the thoracic cavity, measuring 18 × 14.5 × 11 cm had undergone expansive
growth without apparent invasion. The tumor was completely resected without combined resection of the other
organs. The weight of the tumor was 1350 g. The tumor was histologically diagnosed to be type AB thymoma
according to the World Health Organization classification and Masaoka stage IIB.
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Thymoma is an epithelial neoplasm of the thymus,
which commonly lies in the anterior mediastinum and
ectopic thymomas account for only 4% of all thymomas
[1]. Most ectopic thymomas present as superior or infer-
ior mediastinum tumors, therefore intrathoracic origin
was rare [1–3]. Although surgery is the most effective
treatment modality for thymomas, in some cases, it is
difficult to excise due to involvement of surrounding
organs or tumor size. This report presents a case of ec-
topic thymoma that presented as a giant intrathoracic
tumor histologically diagnosed as type AB thymoma and
Masaoka stage IIB.Case presentation
A 61-year-old male presented with chronic cough and
breathlessness. Chest CT revealed a well enhanced giant
mass, approximately 18 cm in diameter in the right thor-
acic cavity (Figure 1). FDG-PET showed that the SUV-
max of the tumor was 5.0 in the center and almost 2.5
in the surrounding areas (Figure 1). A trans-bronchial
biopsy was performed and atypical cells were detected* Correspondence: ttake@surg2.med.kyushu-u.ac.jp
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reproduction in any medium, provided the orfrom the giant tumor. An intrathoracic malignant tumor
was suspected, therefore surgical resection was per-
formed. The CT findings suggested that the mass had
not invaded surrounding organs, but had some adhesion
to the right lung and superior vena cava. Surgical access
to the mass was accomplished through a median
sternotomy with a 4th intercostal thoracotomy of the
right chest wall. A well-defined giant mass measuring
18 × 14.5 × 11 cm was found in the right thoracic cavity.
The feeding vessels of the tumor were branching from
internal thoracic vessels and collateral blood vessels were
extensive surrounding the giant tumor. The tumor was
completely resected without combined resection of the
other organs. The weight of the tumor was 1350 g. The
cut surface of tumor revealed a light brown color, an in-
ternal lobulated structure with a portion of capsulation
invasion (Figure 2). A microscopic examination showed
the tumor to contain spindle shaped cells with a
lymphocyte rich component (Figure 2). Immunohisto-
chemistry showed predominantly lymphocytes expres-
sing CD1a, TdT and CD5. The spindle cells of the tumor
were all negative for EMA, cytokeratin, CAM5.2,αSMA,
S100, CD5, TTF-1 and CD34. These histopathological
findings indicated that the tumor was a type AB thym-
oma according to the World Health Organizational Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 (A) Chest CT showing a huge mass, measuring 18× 14× 11 cm in diameter in the right thoracic cavity. (B) FDG-PET revealed
that SUVmax of the tumor was 5.0 in the center and almost 2.5 in the surrounding areas.
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course was uneventful, and there has been no evidence
of recurrence 6 months after the surgery.
Discussion
Thymomas develop mainly in the thymus and are usu-
ally located in the anterior mediastinum, only 4% of the
tumors are ectopic tumors [1]. Ectopic thymomas have
been reported in the neck, middle or posterior mediasti-
num, lung and pleura, a few reports have described giant
intrathoracic tumors [2, 3].
FDG-PET showing increased uptake of FDG is suggestive
of malignant potential and SUVmax correlates with malig-
nancy in mesenchymal tumors. Several authors reported a
significant correlation between the histological subtype of
thymicepitherial tumors and FDG-PET accumulation [4, 5].
Who type A, AB and B1 tumors have significantly lower
SUV than that of the other types of tumors [4, 5]. In
addition, SUVmax has a close correlation with the Masaoka
stages [5]. SUVmax of the tumor in the current case was
not very high in the proportion to the size. Fortunately, theFigure 2 (A) Gross pathologic finding of the tumor: an encapsulated
an internal lobulated structure with a portion of capsulation invasion. (B)Hi
spindle-shaped epithelial cells with many lymphocytes (original magnificatitumor did not invade the heart or great vessels, therefore
curative resection could be performed. The tumor was
diagnosed to be type AB thymoma according to the World
Health Organization classification and Masaoka stage IIB.
Although thymomas can present as huge masses, the
symptoms and stage may not always correlate with tumor
size. A large tumor size is a significantly poor prognostic
factor of thymomas [6]. Limmer et al. reviewed previously
reported giant thymomas [7]. According to the article, all
of the giant tumors were type A, AB and B1 according to
WHO classification [7]. Interestingly, although a large
tumor size is a poor prognostic factor, the resected giant
thymomas tended to be low-grade thymomas.
Conclusion
This report presented a very rare case of an intrathoracic
giant thymoma, histologically diagnosed as type AB
Masaoka stage IIB. Surgical resection must be considered
regardless of tumor size if curative resection is possible.
FDG-PET is useful modality for preoperatively evaluating
the grade of thymomas.elastic mass. The cut surface of tumor revealed a light brown color,
stological findings of the tumor: the tumor shows a proliferation of
on: 100×).
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